The Why of YY1: Mechanisms of Transcriptional Regulation by Yin Yang 1
Open accessThe DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Abstract
First described in 1991, Yin Yang 1 (YY1) is a transcription factor that is ubiquitously expressed throughout mammalian cells. It regulates both transcriptional activation and repression, in a seemingly context-dependent manner. YY1 has a well-established role in the development of the central nervous system, where it is involved in neurogenesis and maintenance of homeostasis in the developing brain. In neurodevelopmental and neurodegenerative disease, the crucial role of YY1 in cellular processes in the central nervous system is further underscored. In this mini-review, we discuss the various mechanisms leading to the transcriptional activating and repressing roles of YY1, including its role as a traditional transcription factor, its interactions with cofactors and chromatin modifiers, the role of YY1 in the non-coding genome and 3D chromatin organization and the possible implications of the phase-separation mechanism on YY1 function. We provide examples on how these processes can be involved in normal development and how alterations can lead to various diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cohesin Loss Eliminates All Loop Domains
Rao, S. S. P., Huang, S.-C., Glenn St Hilaire, B., Engreitz, J. M., Perez, E. M., Kieffer-Kwon, K.-R., Sanborn, A. L., Johnstone, S. E., Bascom, G. D., Bochkov, I. D., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.026 · Cited by 1,883
Boija, A., Klein, I. A., Sabari, B. R., Dall’Agnese, A., Coffey, E. L., Zamudio, A. V., Li, C. H., Shrinivas, K., Manteiga, J. C., Hannett, N. M., et al. (2018) · Cell · doi:10.1016/j.cell.2018.10.042 · Cited by 1,815
CTCF: Master Weaver of the Genome
Phillips, J. E., & Corces, V. G. (2009) · Cell · doi:10.1016/j.cell.2009.06.001 · Cited by 1,552 · cited 1×
“CTCF itself is, however, not crucial for the majority of enhancer-promoter interactions (Phillips and Corces, 2009).”
BackgroundSOX2 Functions to Maintain Neural Progenitor Identity
Graham, V., Khudyakov, J., Ellis, P., & Pevny, L. (2003) · Neuron · doi:10.1016/s0896-6273(03)00497-5 · Cited by 1,341 · cited 6×
“In murine models, Yy1 conditional knock-out (cKO) induced at an early stage of cortical development, caused an increased apoptosis rate and cell cycle arrest in neuroepithelium and NPCs (Zurkirchen et al., 2019; Dong and Kwan, 2020).”
BackgroundInfluentialShi, Y., Seto, E., Chang, L.-S., & Shenk, T. (1991) · Cell · doi:10.1016/0092-8674(91)90189-6 · Cited by 1,035
YY1 Is a Structural Regulator of Enhancer-Promoter Loops
Weintraub, A. S., Li, C. H., Zamudio, A. V., Sigova, A. A., Hannett, N. M., Day, D. S., Abraham, B. J., Cohen, M. A., Nabet, B., Buckley, D. L., et al. (2017) · Cell · doi:10.1016/j.cell.2017.11.008 · Cited by 992
A direct link between core histone acetylation and transcriptionally active chromatin.
Hebbes, T. R., Thorne, A. W., & Crane-Robinson, C. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb02956.x · Cited by 923
Cohesin and CTCF differentially affect chromatin architecture and gene expression in human cells
Zuin, J., Dixon, J. R., van der Reijden, M. I. J. A., Ye, Z., Kolovos, P., Brouwer, R. W. W., van de Corput, M. P. C., van de Werken, H. J. G., Knoch, T. A., van IJcken, W. F. J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1317788111 · Cited by 779
Transcription factor YY1: structure, function, and therapeutic implications in cancer biology
Gordon, S., Akopyan, G., Garban, H., & Bonavida, B. (2006) · Oncogene · doi:10.1038/sj.onc.1209080 · Cited by 756 · cited 2×
“Multiple mechanisms have been suggested, including post-translational modifications of YY1 (Yao et al., 2001) and co-factor dependency (Gordon et al., 2006).”
BackgroundHuman cohesin compacts DNA by loop extrusion
Kim, Y., Shi, Z., Zhang, H., Finkelstein, I. J., & Yu, H. (2019) · Science · doi:10.1126/science.aaz4475 · Cited by 701
Widespread plasticity in CTCF occupancy linked to DNA methylation
Wang, H., Maurano, M. T., Qu, H., Varley, K. E., Gertz, J., Pauli, F., Lee, K., Canfield, T., Weaver, M., Sandstrom, R., et al. (2012) · Genome Research · doi:10.1101/gr.136101.111 · Cited by 588
CTCF and Cohesin in Genome Folding and Transcriptional Gene Regulation
Merkenschlager, M., & Nora, E. P. (2016) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-083115-022339 · Cited by 518 · cited 1×
“CTCF, a DNA-binding protein, delimits these DNA loops, demarcating isolated chromatin structures that can be as large as 1 Megabase, called topologically associating domains (TADs) (Zuin et al., 2014; Merkenschlager and Nora, 2016; Rao et al., 2017).”
BackgroundNuclear speckles: molecular organization, biological function and role in disease
Galganski, L., Urbanek, M. O., & Krzyzosiak, W. J. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx759 · Cited by 499
Transcription factor trapping by RNA in gene regulatory elements
Sigova, A. A., Abraham, B. J., Ji, X., Molinie, B., Hannett, N. M., Guo, Y. E., Jangi, M., Giallourakis, C. C., Sharp, P. A., & Young, R. A. (2015) · Science · doi:10.1126/science.aad3346 · Cited by 492
Yang, W.-M., Yao, Y.-L., Sun, J.-M., Davie, J. R., & Seto, E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.44.28001 · Cited by 438 · cited 1×
“Several members of this family, such as HDAC1, HDAC2 and HDAC3, interact with YY1 both in vitro and in vivo (Yang et al., 1997).”
BackgroundEverything you have ever wanted to know about Yin Yang 1......
Shi, Y., Lee, J.-S., & Galvin, K. M. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(96)00044-3 · Cited by 436 · cited 1×
“Independent of binding the DNA, YY1 can regulate transcription by protein-protein interactions with other regulators (Galvin and Shi, 1997).”
BackgroundRegulation of Transcription Factor YY1 by Acetylation and Deacetylation
Yao, Y.-L., Yang, W.-M., & Seto, E. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.17.5979-5991.2001 · Cited by 434 · cited 4×
“Besides acetylating or de-acetylating histones, HATs and HDACs modify YY1 itself, regulating its DNA-binding affinity and activity as a transcriptional regulator (Yao et al., 2001).”
BackgroundInfluentialYin Yang 1 Is a Negative Regulator of p53
Sui, G., Affar, E. B., Shi, Y., Brignone, C., Wall, N. R., Yin, P., Donohoe, M., Luke, M. P., Calvo, D., Grossman, S. R., et al. (2004) · Cell · doi:10.1016/j.cell.2004.06.004 · Cited by 424
Global regulation of erythroid gene expression by transcription factor GATA-1
Welch, J. J. (2004) · Blood · doi:10.1182/blood-2004-04-1603 · Cited by 411
Targeted Disruption of Mouse Yin Yang 1 Transcription Factor Results in Peri-Implantation Lethality
Donohoe, M. E., Zhang, X., McGinnis, L., Biggers, J., Li, E., & Shi, Y. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.10.7237 · Cited by 375
Park, K., & Atchison, M. L. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.21.9804 · Cited by 354 · cited 1×
“It was called NF-E1, as it binds the µE1 intron enhancer at the immunoglobulin heavy chain (IgH) locus (Park and Atchison, 1991) or δ, as it binds the delta motif in the promoter of ribosomal protein genes (Hariharan et al., 1991).”
BackgroundTargeting the Notch-regulated non-coding RNA TUG1 for glioma treatment
Katsushima, K., Natsume, A., Ohka, F., Shinjo, K., Hatanaka, A., Ichimura, N., Sato, S., Takahashi, S., Kimura, H., Totoki, Y., et al. (2016) · Nature Communications · doi:10.1038/ncomms13616 · Cited by 352
Lee, J. S., Galvin, K. M., See, R. H., Eckner, R., Livingston, D., Moran, E., & Shi, Y. (1995) · Genes & Development · doi:10.1101/gad.9.10.1188 · Cited by 311
YY1 and CTCF orchestrate a 3D chromatin looping switch during early neural lineage commitment
Beagan, J. A., Duong, M. T., Titus, K. R., Zhou, L., Cao, Z., Ma, J., Lachanski, C. V., Gillis, D. R., & Phillips-Cremins, J. E. (2017) · Genome Research · doi:10.1101/gr.215160.116 · Cited by 299
Hariharan, N., Kelley, D. E., & Perry, R. P. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.21.9799 · Cited by 298
Interaction between transcription factors Spl and YY1
Seto, E., Lewist, B., & Shenk, T. (1993) · Nature · doi:10.1038/365462a0 · Cited by 282 · cited 1×
“Proteinprotein interactions exist between YY1 and DNA-binding cofactors such as SpI (Seto et al., 1993) and c-Myc (Shrivastava et al., 1993).”
BackgroundRole of DNA Methylation in Modulating Transcription Factor Occupancy
Maurano, M. T., Wang, H., John, S., Shafer, A., Canfield, T., Lee, K., & Stamatoyannopoulos, J. A. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.07.024 · Cited by 281
Inhibition of Transcriptional Regulator Yin-Yang-1 by Association with c-Myc
Shrivastava, A., Saleque, S., Kalpana, G. V., Artandi, S., Goff, S. P., & Calame, K. (1993) · Science · doi:10.1126/science.8266081 · Cited by 274
Yin Yang 1 is a critical regulator of B-cell development
Liu, H., Schmidt-Supprian, M., Shi, Y., Hobeika, E., Barteneva, N., Jumaa, H., Pelanda, R., Reth, M., Skok, J., Rajewsky, K., et al. (2007) · Genes & Development · doi:10.1101/gad.1529307 · Cited by 264
Gray, R. S., Abitua, P. B., Wlodarczyk, B. J., Szabo-Rogers, H. L., Blanchard, O., Lee, I., Weiss, G. S., Liu, K. J., Marcotte, E. M., Wallingford, J. B., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1966 · Cited by 225
Characterization of the Transcriptional Regulator YY1
Austen, M., Lüscher, B., & Lüscher-Firzlaff, J. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.3.1709 · Cited by 219 · cited 1×
“Interestingly, YY1 also interacts with histone acetyltransferases (HATs) like p300 (Lee et al., 1995) and CREB binding protein (CBP), activating transcription (Lee et al., 1995; Austen et al., 1997).”
BackgroundTranscription factor YY1 functions as a PcG protein in vivo
Atchison, L. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg124 · Cited by 209 · cited 1×
“YY1 can direct the Polycomb complex to specific DNA loci, initiating methylation of histone 3 lysine 27 (H3K27me3) (Atchison et al., 2003; Wilkinson et al., 2006).”
BackgroundA YY1–INO80 complex regulates genomic stability through homologous recombination–based repair
Wu, S., Shi, Y., Mulligan, P., Gay, F., Landry, J., Liu, H., Lu, J., Qi, H. H., Wang, W., Nickoloff, J. A., et al. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1332 · Cited by 206 · cited 2×
“The interaction with the INO80 complex is also thought to play a role in facilitating the access of YY1 to its target genes (Wu et al., 2007).”
BackgroundDNA binding sites for the transcriptional activator/repressor YY1
Hyde-DeRuyscher, R. P., Jennings, E., & Shenk, T. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.21.4457 · Cited by 199 · cited 1×
“YY1 homodimers bind a relatively small sequence motif (5′-CCGCCATNTT-3′), often found in enhancers and promoters, via the four C2H2 zinc fingers in its C-terminal domain (Hyde-DeRuyscher et al., 1995; Yant et al., 1995; Figure 1).”
BackgroundPolycomb recruitment to DNA in vivo by the YY1 REPO domain
Wilkinson, F. H., Park, K., & Atchison, M. L. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603564103 · Cited by 193 · cited 2×
“YY1 can direct the Polycomb complex to specific DNA loci, initiating methylation of histone 3 lysine 27 (H3K27me3) (Atchison et al., 2003; Wilkinson et al., 2006).”
BackgroundRole of Notch Signaling Pathway in Glioblastoma Pathogenesis
Bazzoni, R., & Bentivegna, A. (2019) · Cancers · doi:10.3390/cancers11030292 · Cited by 193 · cited 1×
“Notch signaling is known to inhibit differentiation and its regulatory mechanisms seem to be vital in neuronal development as well as in GSC maintenance (Bazzoni and Bentivegna, 2019).”
BackgroundYY1 functions with INO80 to activate transcription
Cai, Y., Jin, J., Yao, T., Gottschalk, A. J., Swanson, S. K., Wu, S., Shi, Y., Washburn, M. P., Florens, L., Conaway, R. C., et al. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1276 · Cited by 189
Multiple Mechanisms of Transcriptional Repression by YY1
Galvin, K. M., & Shi, Y. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.7.3723 · Cited by 183 · cited 1×
“Independent of binding the DNA, YY1 can regulate transcription by protein-protein interactions with other regulators (Galvin and Shi, 1997).”
BackgroundTargeted recruitment of a histone H4-specific methyltransferase by the transcription factor YY1
Rezai-Zadeh, N., Zhang, X., Namour, F., Fejer, G., Wen, Y.-D., Yao, Y.-L., Gyory, I., Wright, K., & Seto, E. (2003) · Genes & Development · doi:10.1101/gad.1068003 · Cited by 177 · cited 1×
“In addition to histone 3 modifications, YY1 promotes transcription by the recruitment of the methyltransferase PRMT1, which methylates histone 4 arginine 3 (Rezai-Zadeh et al., 2003).”
BackgroundThe Two Sides of YY1 in Cancer: A Friend and a Foe
Sarvagalla, S., Kolapalli, S. P., & Vallabhapurapu, S. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01230 · Cited by 173
Kaufhold, S., Garbán, H., & Bonavida, B. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0359-2 · Cited by 166
Gabriele, M., Vulto-van Silfhout, A. T., Germain, P.-L., Vitriolo, A., Kumar, R., Douglas, E., Haan, E., Kosaki, K., Takenouchi, T., Rauch, A., et al. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.05.006 · Cited by 163 · cited 7×
“At first glance, YY1 does not seem essential for 3D chromatin organization, as the majority of its binding sites are close to transcription start sites (TSSs) and only a minority is located distal from regulated genes (Gabriele et al., 2017; Varum et al., 2019; Zurkirchen et al., 2019).”
BackgroundInfluentialNuRD mediates activating and repressive functions of GATA‐1 and FOG‐1 during blood development
Miccio, A., Wang, Y., Hong, W., Gregory, G. D., Wang, H., Yu, X., Choi, J. K., Shelat, S., Tong, W., Poncz, M., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2009.336 · Cited by 163
Kurisaki, K., Kurisaki, A., Valcourt, U., Terentiev, A. A., Pardali, K., ten Dijke, P., Heldin, C.-H., Ericsson, J., & Moustakas, A. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.13.4494-4510.2003 · Cited by 162 · cited 1×
“Additionally, YY1 also recruits co-repressors to the DNA, such as Smad family members repressing TGFβ signaling and cell differentiation (Kurisaki et al., 2003).”
BackgroundThe Yin and Yang of YY 1 in tumor growth and suppression
Khachigian, L. M. (2018) · International Journal of Cancer · doi:10.1002/ijc.31255 · Cited by 161 · cited 2×
“YY1 can act as a tumor suppressor or stimulator (Khachigian, 2018).”
BackgroundSalichs, E., Ledda, A., Mularoni, L., Albà, M. M., & de la Luna, S. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000397 · Cited by 147
Yant, S. R., Zhu, W., Millinoff, D., Slightom, J. L., Goodman, M., & Gumucio, D. L. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.21.4353 · Cited by 144 · cited 1×
“YY1 homodimers bind a relatively small sequence motif (5′-CCGCCATNTT-3′), often found in enhancers and promoters, via the four C2H2 zinc fingers in its C-terminal domain (Hyde-DeRuyscher et al., 1995; Yant et al., 1995; Figure 1).”
BackgroundThe Yin and Yang of YY1 in the nervous system
He, Y., & Casaccia‐Bonnefil, P. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05486.x · Cited by 135
Deng, Z., Cao, P. D., Wan, M., & Sui, G. (2010) · Transcription · doi:10.4161/trns.1.2.12375 · Cited by 127
Mutations in the planar cell polarity gene, Fuzzy, are associated with neural tube defects in humans
Seo, J. H., Zilber, Y., Babayeva, S., Liu, J., Kyriakopoulos, P., Marco, P. D., Merello, E., Capra, V., Gros, P., & Torban, E. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr359 · Cited by 116
Aubry, S., Shin, W., Crary, J. F., Lefort, R., Qureshi, Y. H., Lefebvre, C., Califano, A., & Shelanski, M. L. (2015) · PLOS ONE · doi:10.1371/journal.pone.0120352 · Cited by 106
Gabriele, M., Lopez Tobon, A., D'Agostino, G., & Testa, G. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.12.013 · Cited by 103
Knauss, J. L., Miao, N., Kim, S., Nie, Y., Shi, Y., Wu, T., Pinto, H. B., Donohoe, M. E., & Sun, T. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0840-2 · Cited by 96
Beyond Transcription: Roles of Transcription Factors in Pre-mRNA Splicing
Rambout, X., Dequiedt, F., & Maquat, L. E. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00470 · Cited by 95
Molecular Cloning and Functional Characterization of the Transcription Factor YY2
Nguyen, N., Zhang, X. M., Olashaw, N., & Seto, E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402525200 · Cited by 90
Wang, J., Wu, X., Wei, C., Huang, X., Ma, Q., Huang, X., Faiola, F., Guallar, D., Fidalgo, M., Huang, T.-Y., et al. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.02.004 · Cited by 86
YY1 Represses β-Casein Gene Expression by Preventing the Formation of a Lactation-Associated Complex
Raught, B., Khursheed, B., Kazansky, A. V., & Rosen, J. M. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.1752-1763.1994 · Cited by 85
Fuz Mutant Mice Reveal Shared Mechanisms between Ciliopathies and FGF-Related Syndromes
Tabler, J. M., Barrell, W. B., Szabo-Rogers, H. L., Healy, C., Yeung, Y., Perdiguero, E. G., Schulz, C., Yannakoudakis, B. Z., Mesbahi, A., Wlodarczyk, B., et al. (2013) · Developmental Cell · doi:10.1016/j.devcel.2013.05.021 · Cited by 82
YY1 controls Igκ repertoire and B‐cell development, and localizes with condensin on the Igκ locus
Pan, X., Papasani, M. R., Hao, Y., Calamito, M., Wei, F., Quinn, W. J., Basu, A., Wang, J., Hodawadekar, S., Zápražná, K., et al. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.66 · Cited by 79 · cited 2×
“Interactions between YY1 and proteins involved in chromatin organization, such as CTCF and cohesin (Pan et al., 2013; Schwalie et al., 2013), further implicate a role in 3D chromatin organization.”
BackgroundSchwalie, P. C., Ward, M. C., Cain, C. E., Faure, A. J., Gilad, Y., Odom, D. T., & Flicek, P. (2013) · Genome Biology · doi:10.1186/gb-2013-14-12-r148 · Cited by 77 · cited 1×
“Interactions between YY1 and proteins involved in chromatin organization, such as CTCF and cohesin (Pan et al., 2013; Schwalie et al., 2013), further implicate a role in 3D chromatin organization.”
BackgroundPhase Separation, Protein Disorder, and Enhancer Function
Hahn, S. (2018) · Cell · doi:10.1016/j.cell.2018.11.034 · Cited by 71 · cited 2×
“The high concentration of factors in phase-separated droplets would allow rapid interactions of many factors that during in vitro assays would seem too weak (Hahn, 2018).”
BackgroundRole of neuroinflammation and latent transcription factors in pathogenesis of Parkinson’s disease
Pal, R., Tiwari, P. C., Nath, R., & Pant, K. K. (2016) · Neurological Research · doi:10.1080/01616412.2016.1249997 · Cited by 71
Nrf2/ARE Pathway as a Therapeutic Target for the Treatment of Parkinson Diseases
Gureev, A. P., & Popov, V. N. (2019) · Neurochemical Research · doi:10.1007/s11064-018-02711-2 · Cited by 67 · cited 1×
“YY1 regulates the expression of NRF2-mediated anti-oxidant response and the transmembrane transporter SVCT2-dependent import of the protective drug ascorbate (Qiao and May, 2012; Gureev and Popov, 2019), which are key targets for Parkinson’s disease treatment developments.”
BackgroundVarum, S., Baggiolini, A., Zurkirchen, L., Atak, Z. K., Cantù, C., Marzorati, E., Bossart, R., Wouters, J., Häusel, J., Tuncer, E., et al. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2019.03.011 · Cited by 65
Martinez, A. F., Abe, Y., Hong, S., Molyneux, K., Yarnell, D., Löhr, H., Driever, W., Acosta, M. T., Arcos-Burgos, M., & Muenke, M. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.06.026 · Cited by 59 · cited 1×
“For example, a disrupted YY1-binding site in a brain-specific enhancer of ADGRL3 creates a predisposition to attention-deficit/hyperactivity disorder (ADHD) (Martinez et al., 2016).”
BackgroundPcG recruitment by the YY1 REPO domain can be mediated by Yaf2
Wilkinson, F. H., Pratt, H., & Atchison, M. L. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22424 · Cited by 56
Zhang, J., Zhu, Y., Zhang, X.-F., Liu, D.-F., Wang, Y., Yang, C., Shi, G., Peng, Y., Zhang, K., Tian, L., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.08.032 · Cited by 55
Yin Yang 1 sustains biosynthetic demands during brain development in a stage-specific manner
Zurkirchen, L., Varum, S., Giger, S., Klug, A., Häusel, J., Bossart, R., Zemke, M., Cantù, C., Atak, Z. K., Zamboni, N., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09823-5 · Cited by 54
YY1AP, A Novel Co-activator of YY1
Wang, C., Liang, Y., Lin, Y.-S., Shih, H., Jou, Y., & Yu, W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310532200 · Cited by 51
Structure of Yin Yang 1 Oligomers That Cooperate with RuvBL1-RuvBL2 ATPases
López-Perrote, A., Alatwi, H. E., Torreira, E., Ismail, A., Ayora, S., Downs, J. A., & Llorca, O. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.567040 · Cited by 47 · cited 1×
“In contrast to CTCF, however, YY1 binds to a consensus sequence mainly present in enhancers and promoters and is only scarcely associates with insulators (López-Perrote et al., 2014; Beagan et al., 2017; Weintraub et al., 2017).”
BackgroundThe zinc fingers of YY1 bind single-stranded RNA with low sequence specificity
Wai, D. C. C., Shihab, M., Low, J. K. K., & Mackay, J. P. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw590 · Cited by 39 · cited 2×
“It forms homodimers that seem to be stabilized by low specificity RNA binding (Wai et al., 2016).”
BackgroundCritical role of YY1 in cardiac morphogenesis
Beketaev, I., Zhang, Y., Kim, E. Y., Yu, W., Qian, L., & Wang, J. (2015) · Developmental Dynamics · doi:10.1002/dvdy.24263 · Cited by 31
Planar cell polarity gene Fuz triggers apoptosis in neurodegenerative disease models
Chen, Z. S., Li, L., Peng, S. I., Chen, F. M., Zhang, Q., An, Y., Lin, X., Li, W., Koon, A. C., Chan, T., et al. (2018) · EMBO Reports · doi:10.15252/embr.201745409 · Cited by 30
Acetylated YY1 regulates Otx2 expression in anterior neuroectoderm at two cis‐sites 90 kb apart
Takasaki, N., Kurokawa, D., Nakayama, R., Nakayama, J., & Aizawa, S. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601619 · Cited by 30 · cited 2×
“Only acetylated YY1 binds an essential enhancer 5kb upstream of the homeobox gene Otx2 to prompt its expression (Takasaki et al., 2007).”
BackgroundLiu, W., Guo, Q., & Zhao, H. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.09.082 · Cited by 29
Defining the Transcriptional Ecosystem
Silveira, M. A. D., & Bilodeau, S. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.11.022 · Cited by 26 · cited 1×
“The ambivalence of YY1 being a repressing and activating TF fits the proposition of the studies on phase-separation that transcriptional regulation is a dynamic biochemical equilibrium (Silveira and Bilodeau, 2018).”
BackgroundBianchi, M., Crinelli, R., Giacomini, E., Carloni, E., Radici, L., & Magnani, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065932 · Cited by 25
Morales‐Rosado, J. A., Kaiwar, C., Smith, B. E., Klee, E. W., & Dhamija, R. (2018) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.40626 · Cited by 25 · cited 2×
“In humans, YY1 haploinsufficiency causes Gabriele-de Vries syndrome (OMIM #617557) (Gabriele et al., 2017; Morales-Rosado et al., 2018), characterized by psychomotor delay and intellectual disability alongside many comorbidities, including craniofacial dysmorphisms, intra-uterine growth restriction…”
BackgroundJun, G., ZHONG, G. G., & Ming, Z. (2015) · Oncology Letters · doi:10.3892/ol.2015.3068 · Cited by 24 · cited 1×
“Normally, miR-218 is downregulated in glioma (Jun et al., 2015).”
miR‑218 inhibits the proliferation of human glioma cells through downregulation of Yin Yang 1
Gao, Y., Sun, L., Wu, Z., Xuan, C., Zhang, J., You, Y., & Chen, X. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.8063 · Cited by 23
Dong, X., & Kwan, K. M. (2020) · Molecular Brain · doi:10.1186/s13041-020-00643-z · Cited by 23 · cited 4×
“In mouse embryos, YY1 has proven essential for neurodevelopment (Varum et al., 2019; Zurkirchen et al., 2019; Dong and Kwan, 2020).”
BackgroundInfluentialYy1 regulates Senp1 contributing to AMPA receptor GluR1 expression following neuronal depolarization
Wu, T., & Donohoe, M. E. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-019-0582-1 · Cited by 22 · cited 2×
“In mouse neurons, Yy1 and its interacting partner Brd4 activate Senp1, an upstream regulator of glutamate signaling, which plays a pivotal role in neuronal plasticity (Wu and Donohoe, 2019).”
BackgroundMutations in the planar cell polarity gene, Fuzzy, are associated with neural tube defects in humans
Seo, J. H., Zilber, Y., Babayeva, S., Liu, J., Kyriakopoulos, P., Marco, P. D., Merello, E., Capra, V., Gros, P., & Torban, E. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv131 · Cited by 13
Role of YY1 in long-range chromosomal interactions regulating Th2 cytokine expression
Lee, G. R. (2014) · Transcription · doi:10.4161/trns.27976 · Cited by 10 · cited 1×
“Likewise, in T-helper cells, YY1 seems to mainly influence gene expression through long-distance DNA interactions (Lee, 2014).”
BackgroundQiao, H., & May, J. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035746 · Cited by 8 · cited 1×
“YY1 regulates the expression of NRF2-mediated anti-oxidant response and the transmembrane transporter SVCT2-dependent import of the protective drug ascorbate (Qiao and May, 2012; Gureev and Popov, 2019), which are key targets for Parkinson’s disease treatment developments.”
Background
Cited by
Wang, X., Fan, W., Li, N., Ma, Y., Yao, M., Wang, G., He, S., Li, W., Tan, J., Lu, Q., et al. (2023) · Genome Biology · doi:10.1186/s13059-023-02931-y · Cited by 288
Emergence of activation or repression in transcriptional control under a fixed molecular context
Martinez-Corral, R., Friedrich, D., Frömel, R., Velten, L., Gunawardena, J., & DePace, A. H. (2024) · doi:10.1101/2024.05.29.596388 · Cited by 18
“…conformation, post-translational state or other features relevant to its mechanistic functioning have been given for the Drosophila TF Krüppel [9, 10, 11, 12], and many mammalian TFs, including the glucocorticoid receptor [13], FOXO3 [14], Sp3 [15], Myc [16], Yin-Yang 1 [17] and NF-κ B [18, 19].”
A transcription network underlies the dual genomic coordination of mitochondrial biogenesis
Zhang, F., Lee, A., Freitas, A. V., Herb, J. T., Wang, Z.-H., Gupta, S., Chen, Z., & Xu, H. (2024) · eLife · doi:10.7554/elife.96536.3 · Cited by 8
Metadata
- Authors
- Verheul, T. C. J., van Hijfte, L., Perenthaler, E., & Barakat, T. S.
- Venue
- Frontiers in Cell and Developmental Biology
- Publisher
- Frontiers Media SA
- Published
- 2020-09-30
- Volume
- 8
- Pages
- 592164-592164
- ISSN
- 2296-634X (ISSN-L)
- OpenAlex
- W3089729315
- Cited by
- 196
- References
- 85
- FWCI
- 5.81
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.